| Literature DB >> 28921764 |
Scott L Coven1, Eunkyung Song2, Sarah Steward3, Christopher R Pierson4,5, Jennifer R Cope6, Ibne K Ali6, Monica I Ardura2, Mark W Hall3, Melissa G Chung3,7, Rajinder P S Bajwa1.
Abstract
Acanthamoeba encephalitis is a rare, often fatal condition, particularly after HSCT, with 9 reported cases to date in the world literature. Our case was originally diagnosed with ALL at age 3 years, and after several relapses underwent HSCT at age 9 years. At 17 years of age, he was diagnosed with secondary AML for which he underwent a second allogeneic HSCT. He presented with acute-onset worsening neurological deficits on day +226 after the second transplant and a post-mortem diagnosis of Acanthamoeba encephalitis was established, with the aid of the CDC. Published 2017. This article is a U.S. Government work and is in the public domain in the USA.Entities:
Keywords: bone marrow transplantation; infectious disease; secondary leukemia
Mesh:
Year: 2017 PMID: 28921764 DOI: 10.1111/petr.13060
Source DB: PubMed Journal: Pediatr Transplant ISSN: 1397-3142